Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $17,834 | 1,072 | 99.7% |
| Education | $48.93 | 4 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $3,449 | 283 | $0 (2024) |
| PFIZER INC. | $1,411 | 72 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,384 | 70 | $0 (2024) |
| ABBVIE INC. | $1,321 | 79 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,205 | 58 | $0 (2024) |
| Allergan, Inc. | $853.70 | 58 | $0 (2021) |
| Amgen Inc. | $818.54 | 38 | $0 (2024) |
| Lilly USA, LLC | $793.56 | 43 | $0 (2024) |
| Indivior Inc. | $686.68 | 38 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $621.76 | 28 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,222 | 105 | Novo Nordisk Inc ($383.80) |
| 2023 | $2,350 | 122 | Novo Nordisk Inc ($539.92) |
| 2022 | $1,943 | 109 | Novo Nordisk Inc ($494.33) |
| 2021 | $2,170 | 122 | AbbVie Inc. ($488.39) |
| 2020 | $2,916 | 183 | Allergan, Inc. ($741.56) |
| 2019 | $2,106 | 146 | Novo Nordisk Inc ($372.94) |
| 2018 | $1,865 | 139 | Novo Nordisk Inc ($405.86) |
| 2017 | $2,310 | 150 | AstraZeneca Pharmaceuticals LP ($414.96) |
All Payment Transactions
1,076 individual payment records from CMS Open Payments — Page 1 of 44
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $31.94 | General |
| Category: OUD | ||||||
| 12/18/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $29.80 | General |
| Category: Opioid Use Disorder | ||||||
| 12/12/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $23.71 | General |
| Category: PAIN | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $29.32 | General |
| Category: Respiratory | ||||||
| 12/04/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $33.25 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: DERMATOLOGY | ||||||
| 12/04/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $7.58 | General |
| Category: Obesity | ||||||
| 11/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: DIABETES | ||||||
| 11/13/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $22.84 | General |
| 11/13/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: Biological | ||||||
| 11/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $28.03 | General |
| Category: Cardio-renal | ||||||
| 11/05/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 10/24/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: PAIN | ||||||
| 10/23/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $10.53 | General |
| Category: Diabetes | ||||||
| 10/22/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.98 | General |
| Category: Cardio-renal | ||||||
| 10/22/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $27.60 | General |
| Category: OUD | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $30.26 | General |
| Category: Respiratory | ||||||
| 10/09/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Insomnia | ||||||
| 10/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $27.17 | General |
| Category: DIABETES | ||||||
| 10/07/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $7.41 | General |
| Category: Diabetes | ||||||
| 10/03/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/01/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $25.44 | General |
| Category: RESPIRATORY | ||||||
| 09/24/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 2,249 | 3,138 | $457,394 | $223,140 |
| 2022 | 24 | 2,154 | 3,029 | $395,099 | $209,646 |
| 2021 | 31 | 2,350 | 3,099 | $411,437 | $226,072 |
| 2020 | 27 | 2,004 | 2,733 | $350,219 | $171,967 |
All Medicare Procedures & Services
107 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 457 | 1,094 | $173,759 | $79,552 | 45.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 305 | 305 | $79,665 | $45,735 | 57.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 225 | 370 | $75,451 | $38,150 | 50.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 176 | 182 | $19,120 | $13,054 | 68.3% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 34 | 35 | $13,732 | $9,036 | 65.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 185 | 192 | $12,700 | $6,832 | 53.8% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 220 | 220 | $10,018 | $4,969 | 49.6% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 20 | 20 | $5,873 | $3,800 | 64.7% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 42 | 42 | $5,855 | $3,417 | 58.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 260 | 272 | $24,598 | $3,091 | 12.6% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 12 | 12 | $3,434 | $2,274 | 66.2% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 54 | 59 | $5,507 | $2,191 | 39.8% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 11 | 11 | $3,476 | $1,964 | 56.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $4,454 | $1,911 | 42.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 13 | $4,043 | $1,639 | 40.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 15 | 16 | $2,535 | $1,171 | 46.2% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 19 | 19 | $1,376 | $1,018 | 74.0% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 17 | 19 | $1,929 | $889.56 | 46.1% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 23 | 23 | $1,080 | $796.26 | 73.7% |
| 99422 | Online digital evaluation and management service for an established patient for up to 7 days, total time 11-20 minutes | Office | 2023 | 27 | 27 | $2,114 | $711.99 | 33.7% |
| 69209 | Removal of impacted ear wax by washing | Office | 2023 | 24 | 27 | $1,459 | $389.54 | 26.7% |
| 81002 | Urinalysis, manual test | Office | 2023 | 48 | 56 | $2,310 | $190.96 | 8.3% |
| 99421 | Online digital evaluation and management service for an established patient for up to 7 days, total time 5-10 minutes | Office | 2023 | 14 | 14 | $684.78 | $160.44 | 23.4% |
| G0403 | Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report | Office | 2023 | 15 | 15 | $1,449 | $136.10 | 9.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 20 | 80 | $772.00 | $60.79 | 7.9% |
About Dr. Douglas Severance, M.D
Dr. Douglas Severance, M.D is a Family Medicine healthcare provider based in San Ramon, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1639289838.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Douglas Severance, M.D has received a total of $17,882 in payments from pharmaceutical and medical device companies, with $2,222 received in 2024. These payments were reported across 1,076 transactions from 66 companies. The most common payment nature is "Food and Beverage" ($17,834).
As a Medicare-enrolled provider, Severance has provided services to 8,757 Medicare beneficiaries, totaling 11,999 services with total Medicare billing of $830,825. Data is available for 4 years (2020–2023), covering 107 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location San Ramon, CA
- Active Since 08/30/2006
- Last Updated 08/13/2010
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1639289838
Products in Payments
- Ozempic (Drug) $1,502
- JARDIANCE (Drug) $1,349
- VRAYLAR (Drug) $978.13
- ELIQUIS (Drug) $937.70
- UBRELVY (Drug) $681.24
- SUBLOCADE (Drug) $544.88
- Rybelsus (Drug) $536.38
- Zubsolv (Drug) $509.04
- Saxenda (Drug) $484.08
- FARXIGA (Drug) $470.01
- Kerendia (Drug) $465.67
- NURTEC ODT (Drug) $351.92
- Otezla (Drug) $332.77
- Trintellix (Drug) $326.47
- Victoza (Drug) $297.92
- PREVNAR 13 (Biological) $293.42
- Aimovig (Biological) $273.28
- Vascepa (Drug) $264.14
- SYMBICORT (Drug) $256.10
- JANUVIA (Drug) $248.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in San Ramon
Dr. Bradford Flagg, M.d, M.D
Family Medicine — Payments: $12,504
Dr. Ralph Fong, M.d, M.D
Family Medicine — Payments: $4,496
Dr. Rajesh Maheshwari, Md, MD
Family Medicine — Payments: $4,407
Dr. Joseph Toscano, M.d, M.D
Family Medicine — Payments: $4,309
Dr. Erik Gracer, Md, MD
Family Medicine — Payments: $3,695
Mrs. Marjan Naraghi-Arani, D.o, D.O
Family Medicine — Payments: $2,782